APA

Suzuki K., Hattori S., Marks K., Ahlenstiel C., Maeda Y., Ishida T., Millington M., Boyd M., Symonds G., Cooper D. A., Okada S. & Kelleher A. D. (20131204). Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. : Molecular therapy. Nucleic acids.

Chicago

Suzuki Kazuo, Hattori Shinichiro, Marks Katherine, Ahlenstiel Chantelle, Maeda Yosuke, Ishida Takaomi, Millington Michelle, Boyd Maureen, Symonds Geoff, Cooper David A, Okada Seiji and Kelleher Anthony D. 20131204. Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. : Molecular therapy. Nucleic acids.

Harvard

Suzuki K., Hattori S., Marks K., Ahlenstiel C., Maeda Y., Ishida T., Millington M., Boyd M., Symonds G., Cooper D. A., Okada S. and Kelleher A. D. (20131204). Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. : Molecular therapy. Nucleic acids.

MLA

Suzuki Kazuo, Hattori Shinichiro, Marks Katherine, Ahlenstiel Chantelle, Maeda Yosuke, Ishida Takaomi, Millington Michelle, Boyd Maureen, Symonds Geoff, Cooper David A, Okada Seiji and Kelleher Anthony D. Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. : Molecular therapy. Nucleic acids. 20131204.